Meclizine is on the American Geriatrics Society’s Beers Criteria list of medications to avoid in adults over 65. That doesn’t mean it can never be used, but the recommendation against it is strong, backed by moderate-quality evidence linking it to confusion, falls, and other serious side effects in older adults. If you or a family member has been prescribed meclizine for dizziness or vertigo, there are important risks to understand and safer options worth discussing.
Why Meclizine Is Flagged for Older Adults
Meclizine is a first-generation antihistamine with strong anticholinergic properties. Anticholinergic drugs block a chemical messenger in the nervous system that helps regulate muscle contractions, saliva production, urination, memory, and alertness. In younger people, the body can usually compensate for this interference. In older adults, the picture changes significantly.
The liver and kidneys clear meclizine from the body more slowly as people age. That means the drug lingers longer, and its effects stack up with each dose. The brain also becomes more sensitive to anticholinergic interference over time. The result is a higher risk of dry mouth, constipation, urinary retention, confusion, drowsiness, and blurred vision. For someone already dealing with age-related changes in balance, cognition, or bladder function, meclizine can make all of these worse.
The Beers Criteria specifically notes that cumulative exposure to anticholinergic drugs is associated with increased risk of falls, delirium, and dementia. This applies even to “young-old” adults in their 60s, not just those in their 80s and 90s. The concern grows when meclizine is combined with other medications that also have anticholinergic effects, which is common in older adults taking multiple prescriptions.
The Fall Risk Is Measurable
Dizziness already increases fall risk, so a medication meant to treat it should ideally reduce that danger. Meclizine may do the opposite. A study reported in NEJM Journal Watch found that 9% of people who received meclizine experienced an injurious fall within 60 days, compared to 4% of those who did not receive it. After adjusting for other factors, meclizine was associated with a 2.5 times higher risk of injurious falls in patients 65 and older.
Falls are one of the leading causes of hospitalization and loss of independence in older adults. A hip fracture or head injury from a fall can permanently change someone’s quality of life, which is why this particular side effect carries so much weight in the risk calculation.
Cognitive Effects and Confusion
Meclizine’s anticholinergic activity can cause noticeable cognitive changes in older adults. These range from mild fogginess and difficulty concentrating to outright confusion and delirium. For someone with early cognitive decline or dementia, these effects can be especially pronounced and may be mistaken for worsening of the underlying condition rather than a medication side effect.
The concern isn’t limited to short-term confusion. Research on anticholinergic drugs as a class has shown that long-term or repeated use is associated with a higher risk of developing dementia. While meclizine is typically intended for short-term use, it’s frequently prescribed without a clear stop date, and many older adults continue taking it for weeks or months.
Conditions That Increase the Risk
Certain common health conditions in older adults make meclizine especially problematic. If you have an enlarged prostate, meclizine can worsen urinary retention, potentially leading to a medical emergency. Narrow-angle glaucoma can be aggravated because anticholinergic drugs increase pressure inside the eye. People with asthma may also experience worsening symptoms.
Reduced liver, kidney, or heart function, all increasingly common with age, can slow how quickly the body processes and eliminates the drug. The FDA’s prescribing information advises that dosing for elderly patients should start at the low end of the range (the standard dose runs from 25 to 100 mg daily) specifically because of these organ-related concerns.
Safer Ways to Treat Dizziness and Vertigo
The most common cause of vertigo in older adults is benign paroxysmal positional vertigo (BPPV), which happens when tiny calcium crystals in the inner ear shift out of place. The good news is that BPPV responds extremely well to a simple, drug-free treatment called the Epley maneuver. This is a series of guided head movements performed by a healthcare provider, audiologist, or physical therapist that repositions the crystals. It often resolves vertigo faster than medication and carries none of the cognitive or fall risks.
For ongoing dizziness related to inner ear conditions, vestibular rehabilitation is another effective option. This is a type of physical therapy that retrains the balance system through specific exercises, gradually reducing sensitivity to motion and improving stability. It addresses the root problem rather than masking symptoms.
When dizziness is linked to anxiety, which is more common than many people realize, talk therapy with a psychologist or psychiatrist can be effective. For cases where medication is genuinely needed, a healthcare provider can evaluate options with a lower anticholinergic burden than meclizine.
If You’re Already Taking Meclizine
If you or a family member over 65 is currently taking meclizine, don’t stop it abruptly without talking to a prescriber, but do raise the conversation. Ask whether the underlying cause of the dizziness has been identified, whether a non-drug treatment like the Epley maneuver or vestibular rehabilitation could work instead, and how long the medication is actually intended to be used.
It’s also worth asking for a review of all current medications to assess the total anticholinergic load. Many common drugs, including certain bladder medications, sleep aids, and antidepressants, also have anticholinergic effects. When these are combined with meclizine, the risks compound. A pharmacist can help identify which medications on the list contribute to this burden and flag potential interactions.